According to Anthem's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is . At the end of 2022 the company had a P/S ratio of 0.8206.
Year | P/S ratio | Change |
---|---|---|
2022 | 0.8206 | 1.12% |
2021 | 0.8115 | 23.84% |
2020 | 0.6553 | -10.61% |
2019 | 0.7330 | -0.13% |
2018 | 0.7339 | 14.38% |
2017 | 0.6416 | 43.77% |
2016 | 0.4463 | -3.02% |
2015 | 0.4602 | 0.9% |
2014 | 0.4561 | 19.55% |
2013 | 0.3815 | 26.83% |
2012 | 0.3008 | -20.76% |
2011 | 0.3796 | 3.88% |
2010 | 0.3654 | -9.37% |
2009 | 0.4032 | 17.61% |
2008 | 0.3428 | -55.92% |
2007 | 0.7777 | -8.55% |
2006 | 0.8504 | -27.39% |
2005 | 1.17 | -29.95% |
2004 | 1.67 | 171.64% |
2003 | 0.6155 | -6.72% |
2002 | 0.6598 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
Centene CNC | 0.2629 | N/A | ๐บ๐ธ USA |
Cigna CI | 0.5152 | N/A | ๐บ๐ธ USA |
Humana HUM | 0.3529 | N/A | ๐บ๐ธ USA |
UnitedHealth UNH | 1.22 | N/A | ๐บ๐ธ USA |